Blood Irradiation Market Analysis and Forecast to 2031: By Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, Others), En
Description
Blood Irradiation Market Analysis and Forecast to 2031: By Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, Others), End User (Hospitals, Blood Banks, Diagnostic Clinics, Research Institutes), and Region
The global blood irradiation market was valued at USD 66.0 million in 2021 and it is anticipated to grow further till USD 128.1 million in 2031, at a CAGR of 6.9% during the forecast period.
To stop the proliferation of specific types of T cells, blood components are radioactively treated before being transfused. Due to white blood cell transfusion generated by these T lymphocytes, a rare condition known as graft-versus-host disease (GVHD) with serious complications might occur. A small number of white blood cells have the ability to identify the various blood types in the body that can result in fatal sickness or serious illness. UV, X-rays, and other radioactive techniques are used to cure radioactively contaminated blood. Patients with cancer benefit from blood irradiation treated with UV rays because it boosts the immune system and enhances general health.
Market Trends and Drivers
The growth of the global blood irradiation market is anticipated to be fueled by an increasing number of people who are susceptible to various communicable and non-communicable diseases (NCDs), including cancer, chronic renal disease, high blood pressure, stroke, and cardiovascular disorders. For instance, the World Bank's 2016 report estimates that there were 7.44 billion people on the planet. In 2018, the World Health Organization (WHO) reported that non-communicable illnesses were responsible for around 41 million deaths worldwide, or 71% of all fatalities. Additionally, 17.9 million deaths each year are caused by cardiovascular illnesses, which are followed by diabetes (1.6 million), other respiratory diseases (3.9 million), and cancer (9.0 million) in that order. The rising incidence of non-communicable diseases increases consumer desire for faster blood stream treatment, which is anticipated to significantly fuel market expansion for blood irradiation.
Market Restraints and Challenges
The development of the worldwide blood irradiation market is expected to be constrained by medical system regulation legislation and a shortage of qualified specialists in developing economies. Problems and difficulties associated with blood component irradiation include delayed transfusions, high costs, failure to irradiate, when necessary, increased potassium accumulation in and shortened shelf life of RBC units, and decreased RBC recovery.
Global Blood Irradiation Market Segmental Overview
The report analyses the global blood irradiation market based on the type, indication, end user, and region.
Global Blood Irradiation Market by Type
Based on the type, it is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment accounted for the majority of the market share. However, the extracorporeal laser blood irradiation segment is anticipated to grow at the highest CAGR during the forecast period.
Global Blood Irradiation Market by Indication
Based on the indication, it is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment is expected to dominate the market during the forecast period. Likewise, the lymphoma segment is likely to grow at the fastest CAGR during the forecast period.
Global Blood Irradiation Market by End User
Based on the end user, it is segmented into hospitals, blood banks, diagnostic clinics, and research institutes. The hospital segment is likely to dominate the market during the forecast period. Similarly, the blood banks segment is anticipated to register the highest CAGR during the forecast period.
Geographical Analysis of the Global Blood Irradiation Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America region is expected to hold a dominant position during the forecast period. Owing to growing awareness among the population regarding blood-related diseases and the launch of new innovative technology in the field of healthcare.
Major Players in the Global Blood Irradiation Market
The key players studied in the report are
COVID-19 Impact
The COVID-19 epidemic produced by the SARS-CoV-2 coronavirus has had a substantial impact on healthcare systems around the world. The cytokine storm that accompanies lung infection is causally linked to respiratory impairment and mortality in the majority of patients. Governments all over the world instituted lockdowns and restrictions to stop the spread of Covid-19. Global value chains, as well as capabilities for dissemination and coordination, have been significantly impacted by this. Additionally, a number of end-client businesses have suffered significant financial losses as a result of their waning popularity. Anyhow, vaccination will significantly contribute to controlling and managing worldwide pandemics.
Several viral illnesses, including SARS-CoV-2, MERS, HIV/AIDS, Ebola, and SARS, have emerged recently. Brought back to the fore this healing opportunity. Blood irradiation, or BI, has a variety of virucidal effects, but its main immune system-related effects Hematological malignancies are also treated by a more complex process called extracorporeal photopheresis (ECP). For instance, T-cell lymphomas. Additional study into BI might result in the creation of a useful tool that could be used to battle new viruses that are immune to vaccines or known antivirals, as well as bacteria that are resistant to antibiotics. The result is in spite of the pandemic, the market is growing moderately.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global blood irradiation market was valued at USD 66.0 million in 2021 and it is anticipated to grow further till USD 128.1 million in 2031, at a CAGR of 6.9% during the forecast period.
To stop the proliferation of specific types of T cells, blood components are radioactively treated before being transfused. Due to white blood cell transfusion generated by these T lymphocytes, a rare condition known as graft-versus-host disease (GVHD) with serious complications might occur. A small number of white blood cells have the ability to identify the various blood types in the body that can result in fatal sickness or serious illness. UV, X-rays, and other radioactive techniques are used to cure radioactively contaminated blood. Patients with cancer benefit from blood irradiation treated with UV rays because it boosts the immune system and enhances general health.
Market Trends and Drivers
The growth of the global blood irradiation market is anticipated to be fueled by an increasing number of people who are susceptible to various communicable and non-communicable diseases (NCDs), including cancer, chronic renal disease, high blood pressure, stroke, and cardiovascular disorders. For instance, the World Bank's 2016 report estimates that there were 7.44 billion people on the planet. In 2018, the World Health Organization (WHO) reported that non-communicable illnesses were responsible for around 41 million deaths worldwide, or 71% of all fatalities. Additionally, 17.9 million deaths each year are caused by cardiovascular illnesses, which are followed by diabetes (1.6 million), other respiratory diseases (3.9 million), and cancer (9.0 million) in that order. The rising incidence of non-communicable diseases increases consumer desire for faster blood stream treatment, which is anticipated to significantly fuel market expansion for blood irradiation.
Market Restraints and Challenges
The development of the worldwide blood irradiation market is expected to be constrained by medical system regulation legislation and a shortage of qualified specialists in developing economies. Problems and difficulties associated with blood component irradiation include delayed transfusions, high costs, failure to irradiate, when necessary, increased potassium accumulation in and shortened shelf life of RBC units, and decreased RBC recovery.
Global Blood Irradiation Market Segmental Overview
The report analyses the global blood irradiation market based on the type, indication, end user, and region.
Global Blood Irradiation Market by Type
Based on the type, it is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment accounted for the majority of the market share. However, the extracorporeal laser blood irradiation segment is anticipated to grow at the highest CAGR during the forecast period.
Global Blood Irradiation Market by Indication
Based on the indication, it is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment is expected to dominate the market during the forecast period. Likewise, the lymphoma segment is likely to grow at the fastest CAGR during the forecast period.
Global Blood Irradiation Market by End User
Based on the end user, it is segmented into hospitals, blood banks, diagnostic clinics, and research institutes. The hospital segment is likely to dominate the market during the forecast period. Similarly, the blood banks segment is anticipated to register the highest CAGR during the forecast period.
Geographical Analysis of the Global Blood Irradiation Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America region is expected to hold a dominant position during the forecast period. Owing to growing awareness among the population regarding blood-related diseases and the launch of new innovative technology in the field of healthcare.
Major Players in the Global Blood Irradiation Market
The key players studied in the report are
COVID-19 Impact
The COVID-19 epidemic produced by the SARS-CoV-2 coronavirus has had a substantial impact on healthcare systems around the world. The cytokine storm that accompanies lung infection is causally linked to respiratory impairment and mortality in the majority of patients. Governments all over the world instituted lockdowns and restrictions to stop the spread of Covid-19. Global value chains, as well as capabilities for dissemination and coordination, have been significantly impacted by this. Additionally, a number of end-client businesses have suffered significant financial losses as a result of their waning popularity. Anyhow, vaccination will significantly contribute to controlling and managing worldwide pandemics.
Several viral illnesses, including SARS-CoV-2, MERS, HIV/AIDS, Ebola, and SARS, have emerged recently. Brought back to the fore this healing opportunity. Blood irradiation, or BI, has a variety of virucidal effects, but its main immune system-related effects Hematological malignancies are also treated by a more complex process called extracorporeal photopheresis (ECP). For instance, T-cell lymphomas. Additional study into BI might result in the creation of a useful tool that could be used to battle new viruses that are immune to vaccines or known antivirals, as well as bacteria that are resistant to antibiotics. The result is in spite of the pandemic, the market is growing moderately.
Recent Developments
- June 2021, Rad Sources Technolgies, a commercial X-ray radiation production supplier in the US, designed a product to replace self-shielded gamma irradiators and introduced its newly redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021.
- November 2018, JW Bioscience Co. Ltd., a south Korean medical device business, unveiled ‘Sangray’, a blood radiation device.
- September 2017, Typenex Medical launched Rad-Control, a new irradiation tag technology for blood centers and blood banks in Canada and the U.S. This checkss blood irradiation by visual verification, minimizes current documentation practices, and increases efficiency for healthcare staff.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
159 Pages
- Chapter 1. Blood Irradiation Market Overview
- 1.1. Objectives of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Limitations
- 1.4. Research Methodologies
- 1.4.1. Secondary Research
- 1.4.2. Market Size Estimation Technique
- 1.4.3. Forecasting
- 1.4.4. Primary Research and Data Validation
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of the Market
- Chapter 3. Premium Insights on the Market
- 3.1. Market Attractiveness Analysis, by Region
- 3.2. Market Attractiveness Analysis, by Type
- 3.3. Market Attractiveness Analysis, by Application
- 3.4. Market Attractiveness Analysis, by End User
- Chapter 4. Blood Irradiation Market Outlook
- 4.1. Blood Irradiation Market Segmentation
- 4.2. Market Dynamics
- 4.2.1. Market Drivers
- 4.2.1.1. Driver 1
- 4.2.1.2. Driver 2
- 4.2.1.3. Driver 3
- 4.2.2. Market Restraints
- 4.2.2.1. Restraint 1
- 4.2.2.2. Restraint 2
- 4.2.3. Market Opportunities
- 4.2.3.1. Opportunity 1
- 4.2.3.2. Opportunity 2
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Threat of New Entrants
- 4.3.2. Threat of Substitutes
- 4.3.3. Bargaining Power of Buyers
- 4.3.4. Bargaining Power of Supplier
- 4.3.5. Competitive Rivalry
- 4.4. PESTLE Analysis
- 4.5. Value Chain Analysis
- 4.5.1. Raw End User Suppliers
- 4.5.2. Manufacturers
- 4.5.3. Wholesalers and/or Retailers
- 4.6. Impact of COVID-19 on the Blood Irradiation Market
- 4.7. Impact of the Russia and Ukraine War on the Blood Irradiation Market
- Chapter 5. Blood Irradiation Market by Type
- 5.1. Market Overview
- 5.2. Intravenous Laser Blood Irradiation
- 5.2.1. Key Market Trends & Opportunity Analysis
- 5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 5.3. Transcutaneous Laser Blood Irradiation
- 5.3.1. Key Market Trends & Opportunity Analysis
- 5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 5.4. Extracorporeal Blood Irradiation
- 5.4.1. Key Market Trends & Opportunity Analysis
- 5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- Chapter 6. Blood Irradiation Market by Application
- 6.1. Market Overview
- 6.2. Acute Leukemia
- 6.2.1. Key Market Trends & Opportunity Analysis
- 6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 6.3. Lymphoma
- 6.3.1. Key Market Trends & Opportunity Analysis
- 6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 6.4. Solid Tumors
- 6.4.1. Key Market Trends & Opportunity Analysis
- 6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 6.5. Pelvic Tumors
- 6.5.1. Key Market Trends & Opportunity Analysis
- 6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 6.6. Others
- 6.6.1. Key Market Trends & Opportunity Analysis
- 6.6.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- Chapter 7. Blood Irradiation Market by End User
- 7.1. Market Overview
- 7.2. Hospitals
- 7.2.1. Key Market Trends & Opportunity Analysis
- 7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 7.3. Blood Banks
- 7.3.1. Key Market Trends & Opportunity Analysis
- 7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 7.4. Diagnostic Clinics
- 7.4.1. Key Market Trends & Opportunity Analysis
- 7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- 7.5. Research Institutes
- 7.5.1. Key Market Trends & Opportunity Analysis
- 7.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
- Chapter 8. Blood Irradiation Market, by Region
- 8.1. Overview
- 8.2. North America
- 8.2.1. Key Market Trends & Opportunity Analysis
- 8.2.2. North America Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.2.3. North America Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.2.4. North America Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.2.5. North America Blood Irradiation Market Size and Forecast by Country, 2021-2031, ($Million)
- 8.2.6. The U.S.
- 8.2.6.1. The U.S. Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.2.6.2. The U.S. Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.2.6.3. The U.S. Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.2.7. Canada
- 8.2.7.1. Canada Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.2.7.2. Canada Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.2.7.3. Canada Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.2.8. Mexico
- 8.2.8.1. Mexico Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.2.8.2. Mexico Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.2.8.3. Mexico Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3. Europe
- 8.3.1. Key Market Trends & Opportunity Analysis
- 8.3.2. Europe Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.3. Europe Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.4. Europe Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.5. Europe Blood Irradiation Market Size and Forecast by Country, 2021-2031, ($Million)
- 8.3.6. Germany
- 8.3.6.1. Germany Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.6.2. Germany Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.6.3. Germany Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.7. France
- 8.3.7.1. France Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.7.2. France Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.7.3. France Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.8. U.K.
- 8.3.8.1. U.K. Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.8.2. U.K. Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.8.3. U.K. Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.9. Spain
- 8.3.9.1. Spain Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.9.2. Spain Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.9.3. Spain Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.10. Italy
- 8.3.10.1. Italy Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.10.2. Italy Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.10.3. Italy Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.3.11. Rest of Europe
- 8.3.11.1. Rest of Europe Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.3.11.2. Rest of Europe Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.3.11.3. Rest of Europe Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.4. Asia-Pacific
- 8.4.1. Key Market Trends & Opportunity Analysis
- 8.4.2. Asia-Pacific Blood Irradiation Market Size and Forecast by Country, 2021-2031, ($Million)
- 8.4.3. Asia-Pacific Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.4. Asia-Pacific Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.5. Asia-Pacific Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.4.6. China
- 8.4.6.1. China Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.6.2. China Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.6.3. China Blood Irradiation Market Size and Forecast by Product End User, 2021-2031, ($Million)
- 8.4.7. India
- 8.4.7.1. India Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.7.2. India Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.7.3. India Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.4.8. Japan
- 8.4.8.1. Japan Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.8.2. Japan Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.8.3. Japan Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.4.9. South Korea
- 8.4.9.1. South Korea Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.9.2. South Korea Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.9.3. South Korea Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.4.10. Rest of APAC
- 8.4.10.1. Rest of APAC Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.4.10.2. Rest of APAC Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.4.10.3. Rest of APAC Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.5. Rest of the World
- 8.5.1. Key Market Trends & Opportunity Analysis
- 8.5.2. Rest of the World Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.5.3. Rest of the World Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.5.4. Rest of the World Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.5.5. Rest of the World Blood Irradiation Market Size and Forecast by Country, 2021-2031, ($Million)
- 8.5.6. Latin America
- 8.5.6.1. Latin America Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.5.6.2. Latin America Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.5.6.3. Latin America Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.5.7. Middle East
- 8.5.7.1. Middle East Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.5.7.2. Middle East Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.5.7.3. Middle East Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- 8.5.8. Africa
- 8.5.8.1. Africa Blood Irradiation Market Size and Forecast by Type, 2021-2031, ($Million)
- 8.5.8.2. Africa Blood Irradiation Market Size and Forecast by Application, 2021-2031, ($Million)
- 8.5.8.3. Africa Blood Irradiation Market Size and Forecast by End User, 2021-2031, ($Million)
- Chapter 9. Competitive Landscape
- 9.1. Market Overview
- 9.2. Market Share Analysis/Key Player Positioning
- 9.3. Vendor Benchmarking
- 9.4. Developmental Strategy Benchmarking
- 9.4.1. New Product Development
- 9.4.2. Product Launches
- 9.4.3. Business Expansions
- 9.4.4. Partnerships, Joint Ventures, and Collaborations
- 9.4.5. Mergers and Acquisitions
- Chapter 10. Company Profiles
- 10.1. Best Theratronics
- 10.1.1. Company Snapshot
- 10.1.2. Financial Performance
- 10.1.3. Product Offerings
- 10.1.4. Key Strategic Initiatives
- 10.1.5. SWOT Analysis
- 10.2. Hitachi
- 10.2.1. Company Snapshot
- 10.2.2. Financial Performance
- 10.2.3. Product offerings
- 10.2.4. Key Strategic Initiatives
- 10.2.5. SWOT Analysis
- 10.3. Gilardoni
- 10.3.1. Company Snapshot
- 10.3.2. Financial Performance
- 10.3.3. Product offerings
- 10.3.4. Key Strategic Initiatives
- 10.3.5. SWOT Analysis
- 10.4. Gamma-Service
- 10.4.1. Company Snapshot
- 10.4.2. Financial Performance
- 10.4.3. Product offerings
- 10.4.4. Key Strategic Initiatives
- 10.4.5. SWOT Analysis
- 10.5. Cegelec
- 10.5.1. Company Snapshot
- 10.5.2. Financial Performance
- 10.5.3. Product offerings
- 10.5.4. Key Strategic Initiatives
- 10.5.5. SWOT Analysis
- 10.6. Rad Source
- 10.6.1. Company Snapshot
- 10.6.2. Financial Performance
- 10.6.3. Product offerings
- 10.6.4. Key Strategic Initiatives
- 10.6.5. SWOT Analysis
- 10.7. JL SHEPHERD & ASSOCIATES
- 10.7.1. Company Snapshot
- 10.7.2. Financial Performance
- 10.7.3. Product offerings
- 10.7.4. Key Strategic Initiatives
- 10.7.5. SWOT Analysis
- 10.8. Shinva Medical
- 10.8.1. Company Snapshot
- 10.8.2. Financial Performance
- 10.8.3. Product offerings
- 10.8.4. Key Strategic Initiatives
- 10.8.5. SWOT Analysis
- 10.9. NPIC
- 10.9.1. Company Snapshot
- 10.9.2. Financial Performance
- 10.9.3. Product offerings
- 10.9.4. Key Strategic Initiatives
- 10.9.5. SWOT Analysis
- *The list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
